A drug with the SMILES Nc1c(C(=O)CSc2nnc(Nc3ccc(F)cc3)s2)c(=O)[nH]c(=O)n1C1CC1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 0.202%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Nc1c(C(=O)CSc2nnc(Nc3ccc(F)cc3)s2)c(=O)[nH]c(=O)n1C1CC1
Nc1c(C(=O)CSc2nnc(Nc3ccc(F)cc3)s2)c(=O)[nH]c(=O)n1C1CC1
6-amino-1-cyclopropyl-5-[2-[[5-(4-fluoroanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetyl]pyrimidine-2,4-dione